| Mass (MH+)/Da . | Peptide of FtsY . | Peptide of SecY . | P valuea . | Intensity . | Bandb . | ||||
|---|---|---|---|---|---|---|---|---|---|
| Sequencec . | Site . | P valued . | Sequencec . | Site . | P valued . | ||||
| 3011.5843 | K.IITNLTEGASRK.Q | G255 | 4.4 × 10−6 | K.SGAFVPGIUPGEQTAK.Y | R357 | 6.2 × 10−7 | 2.7 × 10−12 | 1.3 × 10+6 | ×2 |
| 3801.921 | R.DAEALYGLLKEEMGEILAK.V | K272 | 2.8 × 10−2 | K.SGAFVPGIUPGEQTAK.Y | R357 | 4.0 × 10−8 | 1.2 × 10−9 | 1.1 × 10+7 | ×2 |
| 3817.9328 | R.DAEALYGLLKEEM*GEILAK.V | K272 | 3.1 × 10−6 | K.SGAFVPGIUPGEQTAK.Y | R357 | 7.4 × 10−3 | 2.3 × 10−8 | 7.4 × 10+6 | ×2 |
| 3801.9419 | R.DAEALYGLLKEEMGEILAK.V | L270 | 1.2 × 10−4 | K.SGAFVPGIUPGEQTAK.Y | R357 | 5.9 × 10−4 | 7.0 × 10−8 | 2.0 × 10+6 | ×2 |
| 3801.9302 | R.DAEALYGLLKEEMGEILAK.V | L271 | 6.2 × 10−6 | K.SGAFVPGIUPGEQTAK.Y | R357 | 7.4 × 10−3 | 4.6 × 10−7 | 1.4 × 10+6 | ×2 |
| 3384.7577 | K.GGVIFSVADQFGIPIR.Y | V456 | 4.8 × 10−7 | K.SGAFVPGIUPGEQTAK.Y | R357 | 3.1 × 10−6 | 1.5 × 10−12 | 3.6 × 10+6 | ×1 |
| 3384.7606 | K.GGVIFSVADQFGIPIR.Y | S459 | 4.0 × 10−6 | K.SGAFVPGIUPGEQTAK.Y | R357 | 6.5 × 10−10 | 2.6 × 10−15 | 3.6 × 10+6 | ×1 |
| 3384.7611 | K.GGVIFSVADQFGIPIR.Y | F464 | 2.4 × 10−4 | K.SGAFVPGIUPGEQTAK.Y | R357 | 1.4 × 10−4 | 3.3 × 10−8 | 3.3 × 10+6 | ×1 |
| 2976.4774 | K.ADDFIEALFAR.E | F488/I489 | 2.1 × 10−4 | K.SGAFVPGIUPGEQTAK.Y | R357 | 6.6 × 10−3 | 1.4 × 10−6 | 8.4 × 10+7 | ×1 |
| Mass (MH+)/Da . | Peptide of FtsY . | Peptide of SecY . | P valuea . | Intensity . | Bandb . | ||||
|---|---|---|---|---|---|---|---|---|---|
| Sequencec . | Site . | P valued . | Sequencec . | Site . | P valued . | ||||
| 3011.5843 | K.IITNLTEGASRK.Q | G255 | 4.4 × 10−6 | K.SGAFVPGIUPGEQTAK.Y | R357 | 6.2 × 10−7 | 2.7 × 10−12 | 1.3 × 10+6 | ×2 |
| 3801.921 | R.DAEALYGLLKEEMGEILAK.V | K272 | 2.8 × 10−2 | K.SGAFVPGIUPGEQTAK.Y | R357 | 4.0 × 10−8 | 1.2 × 10−9 | 1.1 × 10+7 | ×2 |
| 3817.9328 | R.DAEALYGLLKEEM*GEILAK.V | K272 | 3.1 × 10−6 | K.SGAFVPGIUPGEQTAK.Y | R357 | 7.4 × 10−3 | 2.3 × 10−8 | 7.4 × 10+6 | ×2 |
| 3801.9419 | R.DAEALYGLLKEEMGEILAK.V | L270 | 1.2 × 10−4 | K.SGAFVPGIUPGEQTAK.Y | R357 | 5.9 × 10−4 | 7.0 × 10−8 | 2.0 × 10+6 | ×2 |
| 3801.9302 | R.DAEALYGLLKEEMGEILAK.V | L271 | 6.2 × 10−6 | K.SGAFVPGIUPGEQTAK.Y | R357 | 7.4 × 10−3 | 4.6 × 10−7 | 1.4 × 10+6 | ×2 |
| 3384.7577 | K.GGVIFSVADQFGIPIR.Y | V456 | 4.8 × 10−7 | K.SGAFVPGIUPGEQTAK.Y | R357 | 3.1 × 10−6 | 1.5 × 10−12 | 3.6 × 10+6 | ×1 |
| 3384.7606 | K.GGVIFSVADQFGIPIR.Y | S459 | 4.0 × 10−6 | K.SGAFVPGIUPGEQTAK.Y | R357 | 6.5 × 10−10 | 2.6 × 10−15 | 3.6 × 10+6 | ×1 |
| 3384.7611 | K.GGVIFSVADQFGIPIR.Y | F464 | 2.4 × 10−4 | K.SGAFVPGIUPGEQTAK.Y | R357 | 1.4 × 10−4 | 3.3 × 10−8 | 3.3 × 10+6 | ×1 |
| 2976.4774 | K.ADDFIEALFAR.E | F488/I489 | 2.1 × 10−4 | K.SGAFVPGIUPGEQTAK.Y | R357 | 6.6 × 10−3 | 1.4 × 10−6 | 8.4 × 10+7 | ×1 |
Sites of cross-linking are underlined. SecYEG(pBpa) with pBpa incorporated at position 357 of SecY was expressed in vivo and purified after UV exposure of whole cells. Cross-linked FtsY peptides were analyzed as described in the Materials and methods. Residues 198–280 of FtsY correspond to the N domain, and residues 281–497 of FtsY correspond to the GTPase (G) domain.
P value for cross-linked peptide.
Bands from SDS gel at 130 kD (×1) and 160 kD (×2).
Underlined residues signify site of cross-link; M*, oxidized methionine.
Subscores per peptide.